Align Technology | ALGN - 债务利息支出



金融业
股票价格
USD
资产
USD 6.31B
现金及等价物
USD 1.06B
销售成本
USD 303.5M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 114.45M
EBIT
USD 178.05M
EBITDA
USD 260.87M
员工
20.95K
EPS每股收益
USD 2.58
股本和储备
USD 4.15B
销售毛利
USD 736.59M
债务利息支出
USD 16.05M
利息收入
USD 4.62M
贷款资金
USD 0
市值
USD 12.37B
净收入
USD 112.77M
营业费用
USD 862.03M
营业利润
USD 178.05M
普通股股本
USD 71.62M
PE价格收益
22.78
税前利润
USD 148.89M
销售收入
USD 1.04B
销售和管理费用
USD 465.34M
股票
USD 214.94M
贸易债权人
USD 123.72M
应收帐款人
USD 1.13B


债务利息支出 更改 日
3M USD 214M 18M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
Becton, Dickinson and Co. USD 149M 4M 2026-03
Bruker USD 8.1M 11.9M 2025-12
Cardinal Health USD 101M 13M 2026-03
Charles River Laboratories USD 26.74M 2.97M 2026-03
Cooper Companies USD 22.4M 2M 2025-12
CVS Health USD 774M 13M 2026-03
Danaher USD 63M 8M 2026-03
Dentsply International USD 24M 2M 2026-03
Dexcom USD 4.2M 500K 2025-12
Henry Schein USD 39M 0 2026-03
Idexx Laboratories USD 7.74M 2.34M 2026-03
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Masimo USD 6.1M 1.4M 2026-03
McKesson USD 63M 11M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Revvity USD 24.72M 1.2M 2026-03
Solventum Corp USD 14.1B 14.05B 2026-03
Stryker USD 46.29B 45.68B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03
Veeva Systems USD 65.1M 8.4M 2025-03
Waters USD 42M 33.38M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03
Zoetis USD 62M 5M 2026-03